Literature DB >> 28267527

The underdilation of nitinol stents at TIPS implantation: Solution or illusion?

Ashkan Mollaiyan1, Dominik Bettinger2, Martin Rössle3.   

Abstract

PURPOSE: This study investigates the behaviour of self-expanding nitinol stents at the time of TIPS-implantation and thereafter.
METHODS: Hundred consecutive patients with cirrhosis receiving a TIPS revision were included. The smallest stent diameter was measured radiologically immediately after implantation and before shunt revision. Accuracy of the measurement was assessed by comparing the nominal stent diameter with the largest stent diameter measured at the time of revision.
RESULTS: Pearson correlation between largest measured and nominal diameters was excellent (r=0.952, p<0.001) showing that measurements are accurate. At TIPS implantation all stents were markedly underdilated reaching only 76-92% of their nominal diameter. Smallest measured diameters were similar (8mm) irrespective of the nominal diameter (8, 9, 10mm) of the stent. In addition, smallest diameters of 10mm stents were similar irrespective whether 8, 9 or 10mm balloons were used. During a mean follow-up of 12.7±17.8months (median 3 months, range 1-81) stents expanded by 0.5-1.6mm dependent on the nominal stent size (8, 9, 10mm) and the grade of primary underdilation. No significant difference was found between Viatorr and bare stents.
CONCLUSIONS: At TIPS-implantation, the compliance of the surrounding tissue predominantly determines the stent diameter. The nominal size of the stent or the dilatation balloon has little influence. Accurate adjustment of a desired pressure gradient is, therefore, not possible. During follow-up, stents expand towards their nominal diameter questioning the usefulness of underdilation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatic encephalopathy; Stent; TIPS; Transjugular intrahepatic portosystemic shunt

Mesh:

Substances:

Year:  2017        PMID: 28267527     DOI: 10.1016/j.ejrad.2017.01.032

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients.

Authors:  Nathan E Frenk; Teodora Bochnakova; Suvranu Ganguli; Nathaniel Mercaldo; Andrew S Allegretti; Daniel S Pratt; Kei Yamada
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

Review 2.  Interventional Management of Portal Hypertension in Cancer Patients.

Authors:  Max Kabolowsky; Lyndsey Nguyen; Brett E Fortune; Ernesto Santos; Sirish Kishore; Juan C Camacho
Journal:  Curr Oncol Rep       Date:  2022-08-12       Impact factor: 5.945

3.  External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.

Authors:  Sara E Chapin; David S Goldberg; David E Kaplan; Nadim Mahmud
Journal:  Dig Dis Sci       Date:  2021-11-19       Impact factor: 3.487

Review 4.  Where does TIPS fit in the management of patients with cirrhosis?

Authors:  Juan Carlos García-Pagán; Saad Saffo; Mattias Mandorfer; Guadalupe Garcia-Tsao
Journal:  JHEP Rep       Date:  2020-05-23

5.  Guidelines on the management of ascites in cirrhosis.

Authors:  Guruprasad P Aithal; Naaventhan Palaniyappan; Louise China; Suvi Härmälä; Lucia Macken; Jennifer M Ryan; Emilie A Wilkes; Kevin Moore; Joanna A Leithead; Peter C Hayes; Alastair J O'Brien; Sumita Verma
Journal:  Gut       Date:  2020-10-16       Impact factor: 23.059

6.  Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.

Authors:  Michael Praktiknjo; Jasmin Abu-Omar; Johannes Chang; Daniel Thomas; Christian Jansen; Patrick Kupczyk; Filippo Schepis; Juan Carlos Garcia-Pagan; Manuela Merli; Carsten Meyer; Christian P Strassburg; Claus C Pieper; Jonel Trebicka
Journal:  JHEP Rep       Date:  2021-03-03

7.  Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation.

Authors:  Jiacheng Liu; Jinqiang Ma; Chen Zhou; Chongtu Yang; Songjiang Huang; Qin Shi; Bin Xiong
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

Review 8.  Unsolved Questions in Salvage TIPSS: Practical Modalities for Placement, Alternative Therapeutics, and Long-Term Outcomes.

Authors:  Charlotte Bouzbib; Philippe Sultanik; Dominique Thabut; Marika Rudler
Journal:  Can J Gastroenterol Hepatol       Date:  2019-04-01

Review 9.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.